Role of imaging in interventions on structural heart disease

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 12, 2013, Pages 1659-1676

  Carminati, Mario ^a   Agnifili, Mauro ^b   Arcidiacono, Carmelo ^a   Brambilla, Nedy ^b   Bussadori, Claudio ^a   Butera, Gianfranco ^a   Chessa, Massimo ^a   Heles, Mohammed ^a   Micheletti, Angelo ^a   Negura, Diana G ^a   Piazza, Luciane ^a   Saracino, Antonio ^a   Testa, Luca ^b   Tusa, Maurizio ^b   Bedogni, Francesco ^b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b Sant'Ambrogio Hospital   (Italy)

Author keywords

Interventional cardiology; Multimodality cardiac imaging; Non invasive imaging techniques; Patient selection; Percutaneous treatment; Procedural guidance; Structural heart disease

Indexed keywords

ANTIVITAMIN K;

AORTA COARCTATION; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; HEALTH CARE PLANNING; HEART ATRIUM APPENDAGE; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE REPLACEMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTERVENTIONAL RADIOLOGY; INTRACARDIAC ECHOCARDIOGRAPHY; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PATIENT MONITORING; PATIENT SELECTION; REVIEW; SEPTAL OCCLUDER; THROMBOEMBOLISM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCRANIAL DOPPLER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; X RAY;

ADULT; CARDIAC CATHETERIZATION; CHILD; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; HEART DEFECTS, CONGENITAL; HEART DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MULTIMODAL IMAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS;

EID: 84888030254     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2013.854166     Document Type: Review

References (77)

1. Balzer J, van Hall S, Rassaf T et al. Feasibility, safety, and efficacy of real-time three-dimensional transoesophageal echocardiography for guiding device closure of interatrial communications: initial clinical experience and impact on radiation exposure. Eur. J. Echocardiogr. 11, 1-8 (2010).
2. Perk G, Lang RM, Garcia-Fernandez MA et al. Use of real time three-dimensional transesophageal echocardiography in intracardiac catheter based interventions. J. Am. Soc. Echocardiogr. 22, 865-882 (2009).
3. Lodato JA, Cao QL, Weinert L et al. Feasibility of real-time three-dimensional transoesophageal echocardiography for guidance of percutaneous atrial septal defect closure. Eur. J. Echocardiogr. 10, 543-548 (2009).
4. Taniguchi M, Akagi T, Watanabe N et al. Application of real-time three-dimensional transesophageal echocardiography using a matrix array probe for transcatheter closure of atrial septal defect. J. Am. Soc. Echocardiogr. 22, 1114-1120 (2009).
5. Kim SS, Hijazi ZM, Lang RM, Knight BP. The use of Intracardiac Echocardiography and other intracardiac imaging tools to guide noncoronary cardiac interventions. JACC 53, 2117-2128 (2009).
6. Van Camp G, Franken P, Melis P, Cosyns B, Schoors D, Vanoverschelde JL. Comparison of transthoracic echocardiography with second harmonic imaging with transesophageal echocardiography in the detection of right to left shunts. Am. J. Cardiol. 86, 1284-1287, A9 (2000).
7. Cheng TO. The proper conduct of Valsalva maneuver in the detection of patent foramen ovale. JACC 45, 1145-1146 (2005).
8. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 67, 919-920 (2006).
9. Rudolph AM. Ventricular septal defect. In: Rudolph AM (Ed.). Congenital Diseases of the Heart: Clinical-Physiological Considerations (2nd edition). Futura Publishing Company, Armonk NY, 197-244 (2001).
10. Chen Q, Chen LW, Wang QM, Cao H, Zhang GC, Chen DZ. Intraoperative device closure of doubly committed subarterial ventricular septal defects: initial experience. Ann. Thorac. Surg. 90, 869-874 (2010).
11. Dall'Agata A, Cromme-Dijkhuis AH, Meijboom FJ et al. Three-dimensional echocardiography enhances the assessment of ventricular septal defect. Am. J. Cardiol. 83, 1576-1579 (1999).
12. Mercer-Rosa L, Seliem MA, Fedec A, Rome J, Rychik J, Gaynoret JW. Illustration of the additional value of real-time 3-dimensional echocardiography to conventional transthoracic and transesophageal 2-dimensional echocardiography in imaging muscular ventricular septal defects: Does this have any impact on individual patient treatment. J. Am. Soc. Echocardiogr. 19, 1511-1519 (2006).
13. Roos-Hesselink JW, Simoons ML, Bogers AJJC et al. Feasibility and accuracy of real-time 3-dimensional echocardiographic assessment of ventricular septal defects. J. Am. Soc. Echocardiogr. 19, 7-13 (2006).
14. Simpson JM, Miller O. Three-dimensional echocardiography in congenital heart disease. Arch. Cardiovasc. Dis. 104, 45-56 (2011).
15. Artis NJ, Thomson J, Plein S, Greenwood JP. Percutaneous closure of postinfarction ventricular septal defect: cardiac magnetic resonance-guided case selection and postprocedure evaluation. Can. J. Cardiol. 27, 869.e3-869.e5 (2011).
16. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 78, 361-368 (1988).
17. Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter. Cardiovasc. Interv. 46, 43-48 (1999).
18. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: immediate results and intermediate follow-up. Am. Heart J. 138, 339-344 (1999).
19. Sideris EB, Walsh KP, Haddad JL, Chen C, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defect by the buttoned device. 'Buttoned device' clinical Trials International Register. Heart 77, 276-279 (1997).
20. Bridges ND, Perry SB, Keane JF et al. Preoperative transcatheter closure of congenital muscular ventricular septal defects. N. Engl. J. Med. 324, 1312-1317 (1991).
21. Kalra GS, Verma PK, Singh S, Arora R. Transcatheter closure of ventricular septal defect using detachable steel coil. Heart 82, 395-396 (1999).
22. Latiff HA, Alwi M, Kandhavel G, Samion H, Zambahari R. Transcatheter closure of multiple muscular ventricular septal defects using Gianturco coils. Annu. Thorac. Surg. 68, 1400-1401 (1999).
23. Chaudari M, Chessa M, Stumper O, De Giovanni JV. Transcatheter coils closure of muscular ventricular septal defects. J. Invasive Cardiol. 14, 165-168 (2001).
24. Amin Z, Gu X, Berry JM et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation 100, 320-328 (1999).
25. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder: initial clinical applications in children. JACC 33, 1935-1939 (1999).
26. Gu X, Han YM, Titus JL et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter. Cardiovasc. Interv. 50, 502-509 (2000).
27. Bass JL, Kalra GS, Arora R, Gavora P, Thanopoulos BD, Torres W. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter. Cardiovasc. Interv. 58, 238-245 (2003).
28. Chessa M, Carminati M, Cao QL et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J. Invasive Cardiol. 14, 322-327 (2002).
29. Butera G, Carminati M, Chessa M et al. Transcatheter closure of perimembranous ventricular septal defects. early and long-term results. JACC 50, 1189-1195 (2007).
30. Halpern DG, Perk G, Ruiz C, Marino N, Kronzon I. Percutaneous closure of a post-myocardial infarction ventricular septal defect guided by real-time three-dimensional echocardiography. Eur. J. Echocardiogr. 10, 569-571 (2009).
31. Cao QL, Zabal C, Koenig P, Sandhu S, Hijazi ZM. Initial clinical experience with intracardiac echocardiography in guiding transcatheter closure of perimembranous ventricular septal defects: Feasibility and comparison with transesophageal echocardiography. Catheter. Cardiovasc. Interv. 66, 258-267 (2005).
32. Ratnayaka K, Raman VK, Faranesh AZ et al. Antegrade percutaneous closure of membranous ventricular septal defect using X-ray fused with MRI (XFM). JACC Cardiovasc. Interv. 2, 224-230 (2009).
33. Ratnayaka K, Saikus CE, Faranesh AZ et al. Closed-chest transthoracic magnetic resonance imaging-guided ventricular septal defect closure in swine. JACC Cardiovasc. Interv. 4, 1326-1334 (2011).
34. Ruiz CE, Jelnin V, Kronzon I et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. JACC 58, 2210-2217 (2011).
35. Rihal CS, Sorajja P, Booker JD, Hagler DJ, Cabalka AK. Principles of percutaneous paravalvular leak closure. JACC Cardiovasc. Interv. 5, 121-130 (2012).
36. Nielsen JC, Powell AJ, Gauvreau K, Marcus EN, Prakash A, Geva T. Magnetic resonance imaging predictors of coarctation severity. Circulation 111, 622-628 (2005).
37. Didier D, Saint-Martin C, Lapierre C et al. Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography; correlation with echocardiography and surgery. Int. J. Cardiovasc. Imaging 22, 457-475 (2006).
38. Muzzarelli S, Meadows AK, Ordovas KG et al. Usefulness of cardiovascular magnetic resonance imaging to predict the need for intervention in patients with coarctation of the aorta. Am. J. Cardiol. 109, 861-865 (2012).
39. Kilner PJ. The role of cardiovascular magnetic resonance in adults with congenital heart disease. Progress Cardiovasc. Dis. 54, 295-304 (2011).
40. Eichhorn JG, Fink C, Delorme S et al. Magnetic resonance blood flow measurements in the follow-up of pediatric patients with aortic coarctation - A re-evaluation. Internat. J. Cardiol. 113, 291-298 (2006).
41. Prakash A, Powell AJ, Geva T. Multimodality non-invasive imaging for assessment of congenital heart disease. Circ. Cardiovasc. Imaging 3, 112-125 (2010).
42. Chessa M, Carrozza M, Butera G et al. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur. Heart J. 26, 2728-2732 (2005).
43. Hassan W, Awad M, Fawzy ME et al. Long-term effects of balloon angioplasty on left ventricular hypertrophy in adolescent and adult patients with native coarctation of the aorta. Up to 18 years follow-up results. Catheter. Cardiovasc. Interv. 70, 881-886 (2007).
44. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J. Cardiovasc. Magn. Reson. 13, 9 (2011).
45. Lurz P, Gaudin R, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation. Semin. Thorac. Cardiovasc. Surg.: Ped. Cardiac Surg. Ann. 12, 112-117 (2009).
46. Piazza L, Chessa M, Giamberti A et al. Timing of pulmonary valve replacement after tetralogy of Fallot repair. Expert Rev. Cardiovasc. Ther. 10, 917-923 (2012).
47. Zahn EM, Hellenbrand WE, Lock JE. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit. JACC 54, 1722-1729 (2009).
48. Eicken A, Ewert P, Hager A et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100. patients. Eur. Heart J. 32, 1260-1265 (2011).
49. Burchill LJ, Wald RM, Harris L, Colman JM, Silversides CK. Pulmonary valve replacement in adults with repaired tetralogy of Fallot. Semin. Thorac. Cardiovasc. Surg. 14, 92-97 (2011).
50. Nkomo VR, Gardin JM, Skelton TN et al. Burden of valvular heart diseases. Lancet 368, 1005-1011 (2006).
51. Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). JACC 48, e1-148 (2006).
52. Lung B, Baron G, Butchart EG et al. Prospective survey of patients with valvular heart disease in Europe. Eur. Heart J. 24, 1231-1243 (2003).
53. Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116, 755-763 (2007).
54. Leipsic J, Gurvitch R, Labounty TM et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc. Imaging 4, 416-429 (2011).
55. Moss RR, Ivens E, Pasupati S et al. Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc. Imaging 1, 15-24 (2008).
56. Ng AC, Delgado V, van der Kley F et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ. Cardiovasc. Imaging 3, 94-102 (2010).
57. Tops LF, Wood DA, Delgado V et al. Non-invasive evaluation of the aortic root with multislice computed tomography. Implications for transcatheter aortic valve replacement. JACC Cardiovasc. Imaging 1, 321-330 (2008).
58. Anderson RH, Lal M, Ho SY. Anatomy of the aortic root with particular emphasis on options for its surgical enlargement. J. Heart Valve Dis. Suppl. 3, 249-257 (1996).
59. Tamborini G, Fusini L, Gripari P et al. Feasibility and accuracy of 3DTEE versus CT for the evaluation of aortic valve annulus to left main ostium distance before transcatheter aortic valve implantation. JACC Cardiovasc. Imaging 5, 579-588 (2012).
60. Messika-Zeitoun D, Serfaty JM, Brochet E et al. Multimodal assessment of the aortic annulus diameter. JACC 55, 186-194 (2010).
61. Bedogni F, Laudisa ML, Pizzocri S et al. Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprostheses. JACC Cardiovasc. Interv. 4, 1228-1234 (2011).
62. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Annu. Intern. Med. 131, 492-501 (1999).
63. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22, 983-988 (1991).
64. Kanderian A, Gillinov M, Gosta B, Petterson B, Blackstone E, Klein A. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. JACC 52, 924-929 (2008).
65. Reddy VY, Holmes DR, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure. Results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 123, 417-424 (2011).
66. Lockwood S, Alison J, Obeyesekere M, Mottram P. Imaging the left atrial appendage prior to, during and after occlusion. JACC. Cardiovasc. Imaging 4, 303-306 (2011).
67. Feldman T, Foster E, Glower DG et al. Percutaneous repair or surgery for mitral regurgitation. N. Engl. J. Med. 364, 1395-1406 (2011).
68. Feldman T, Kar S, Rinaldi M et al. Percutaneous mitral repair with the Mitra Clip System: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. JACC 54, 686-694 (2009).
69. Maisano F, La Canna G, Colombo A, Alfieri O. The evolution from surgery to percutaneous mitral valve interventions. JACC 58, 2174-2182 (2011).
70. Zoghbi WA, Enriquez-Sarano M, Foster E et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J. Am. Soc. Echocardiogr. 16, 777-802 (2003).
71. Foster E, Wasserman HS, Gray W et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am. J. Cardiol. 100, 1577-1583 (2007).
72. Pristipino C, Anzola GP, Ballerini L et al. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary. Catheter. Cardiovasc. Interv. 82, 122-129 (2013).
73. Maffè S, Dellavesa P, Zenone F et al. Transthoracic second harmonic two and three-dimensional echocardiography for detection of patent foramen ovale. Eur. J. Echocardiogr. 11, 57-63 (2010).
74. Clarke NR, Timperley J, Kelion AD, Banning AP. Trannsthoracic echocardiography using second harmonic imaging with Valsalva maneuver for the detection of right to left shunts. Eur. J. Echocardiogr. 5, 176-181 (2004).
75. Madala D, Zaroff JG, Hourigan L, Foster E. Harmonic imaging improves sensitivity at the expense of specificity in the detection of patent foramen ovale. Echocardiography 21, 33-36 (2004).
76. Stolz E, Kaps M, Kern A, Dorndorf W. Frontal bone windows for transcranial color-coded duplex sonography. Stroke 30, 814-820 (1999).
77. Van H, Poommipanit P, Shalaby M, Gevorgyan R, Tseng CH, Tobis J. Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt. JACC Cardiovasc. Imaging 3, 343-348 (2010).